http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101669095-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101669095-B1 |
| titleOfInvention | Matrix Type Transdermal patch containing Granisetron and the treating method of vomitting thereby |
| abstract | The present invention relates to a matrix type transdermal patch comprising granitectone, and a method for treating and preventing vomiting using the same. The present invention provides a matrix type transdermal patch comprising granitolone, In addition, it is possible to reduce the concentration fluctuation caused by the absorption and metabolism during oral administration and to maintain the blood concentration of the drug with a short half-life constant for a desired period of time, It is manufactured in a small size to increase the convenience of the patient, and the adhesive property can be improved to minimize skin irritation. |
| priorityDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.